<DOC>
	<DOCNO>NCT02245529</DOCNO>
	<brief_summary>The Objective study conduct Prescription Event Monitoring ( PEM ) involve patient treat Secotex® ( Tamsulosin ) `` real life '' setting . The aim PEM monitor safety profile Secotex® cohort patient Benign Prostatic Hyperplasia use general practice</brief_summary>
	<brief_title>Safety Profile Secotex ® Patients With Benign Prostatic Hyperplasia</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<criteria>Patients age diagnosis symptomatic Benign Prostatic Hyperplasia ( BPH ) and/or , accord Physician , symptom require medical treatment improve quality life . The patient could naïve treatment could treatment drug respond adequately treatment . This study noninterventional , decision treat must base best standard accept clinical practice , accord Secotex® prescribe information Patients know hypersensitivity Tamsulosin , component product Patients history orthostatic hypotension severe liver failure</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>